L.S. STARRETT COMPANY acquired by MIDDLEGROUND CAPITAL

Thermo Fisher Scientific has finalized the acquisition of Olink Holding AB, an operation designed to fundamentally strengthen the group's capabilities in the high-growth proteomics market. The strategic rationale for this transaction centers on a "platform-complementarity" play, merging the target's industry-leading protein analysis technology with the group’s established leadership in mass spectrometry and life sciences instrumentation. This fusion effectively creates a specialized powerhouse in the protein biomarker discovery arena, providing the organization with the necessary technical operational depth to address the increasing demand for precision medicine solutions

Spectris has acquired SciAps. SciAps will be integrated into Malvern Panalytical (Spectris Scientific division). The acquisition accelerates Spectris's digital strategy by moving analysis "closer to the sample" (from lab to field). SciAps' handheld XRF and LIBS devices complement Malvern Panalytical's benchtop range, creating a comprehensive suite for customers in mining, recycling, and batteries.

Ambienta, one of Europe�s largest asset managers entirely focused on environmental sustainability, has announced the acquisition of a majority stake in Babcock Wanson Group. The firm is acquiring the stake alongside Kartesia, the current shareholder who is reinvesting a portion of its proceeds, and the company's management team. The transaction, announced in June 2024, is expected to close in Q3 2024.

Interpump Group has finalized the acquisition of 100% of the capital of Alfa Valvole S.r.l. from the U.S.-based IDEX Corporation. This strategic transaction marks a significant enhancement of the group’s fluid management portfolio, integrating high-end valve technology with its existing pump and hydraulic systems. The strategic rationale for the move centers on the high degree of industrial synergy between the target’s integrated solutions for process fluids and the group’s broader global operations in water treatment, mining, and energy sectors

Triton acquired the Trench business from Siemens Energy. The deal allows Siemens Energy to sharpen its portfolio while giving Trench the independence to invest in capacity expansion to meet the booming demand for grid infrastructure. Triton supported the carve-out and setup of standalone functions.

Ingersoll Rand has successfully finalized a definitive agreement to acquire 100% of ILC Dover from New Mountain Capital, marking a transformative expansion into the life sciences sector. This strategic transaction establishes a dedicated life sciences platform within the group’s Precision and Science Technologies (P&ST) segment, consolidating the target’s expertise with the group’s existing brands to create a $700 million revenue vertical. The strategic rationale for the move centers on the convergence of the target’s innovative single-use biopharma solutions with the group’s established liquid handling and positive displacement pump technologies

Astorg has preempted the sale process of Steliau Technology to become its new majority shareholder, marking the company’s fourth LBO. Orchestrated by DDA & Cie, The transaction was financed via an unitranche debt structure, following the model of the previous LBO cycle. This strategic partnership is strictly engineered to accelerate Steliau's pan-European consolidation strategy, specifically targeting new entries into the German, UK, and Scandinavian markets to capitalize on the highly fragmented €3Bn European electronic distribution sector

IK Partners, through its IK X Fund, has entered into exclusive negotiations to acquire a majority stake in Eurofeu, a leading player in the French fire protection market. IK is acquiring the stake from CAPZA and the management team, both of whom will be reinvesting to support the Group's next development phase.

The merger between Standard BioTools and SomaLogic creates a diversified and scaled leader in the life sciences tools industry. The strategic rationale for this transaction centers on a "multi-omic integration" play, merging the target's technical operational depth in proteomics with the group's established mass cytometry and microfluidics platforms. This fusion effectively creates a specialized powerhouse capable of delivering clinical research insights with high throughput and data quality across approximately 50 countries

The successful acquisition of Advanced Micro Instruments (AMI) by Enpro Inc. marks a decisive tactical expansion of the group’s capabilities within the compositional analysis market. This transaction facilitates the integration of Advanced Micro Instruments' proprietary sensing technologies into Enpro Inc.’s Sealing Technologies segment, creating a broader portfolio of solutions for safeguarding critical environments. The strategic rationale hinges on the fusion of Advanced Micro Instruments’ gas analysis expertise with Enpro Inc